The stock has a 36-month beta value of 1.39. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for CDMO is 63.08M, and at present, short sellers hold a 17.75% of that float. On January 15, 2025, the average trading volume of CDMO was 1.96M shares.
CDMO) stock’s latest price update
Avid Bioservices Inc (NASDAQ: CDMO) has experienced a decline in its stock price by -0.24 compared to its previous closing price of 12.42. However, the company has seen a gain of 0.28% in its stock price over the last five trading days. accesswire.com reported 2025-01-15 that NEW YORK CITY, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. (“Avid”) (NASDAQ:CDMO) and GHO Capital Partners and Ampersand Capital Partners. Investors who purchased Avid and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CDMO.
CDMO’s Market Performance
Avid Bioservices Inc (CDMO) has experienced a 0.28% rise in stock performance for the past week, with a 0.65% rise in the past month, and a 22.31% rise in the past quarter. The volatility ratio for the week is 0.37%, and the volatility levels for the past 30 days are at 0.48% for CDMO. The simple moving average for the last 20 days is 0.41% for CDMO’s stock, with a simple moving average of 25.87% for the last 200 days.
Analysts’ Opinion of CDMO
KeyBanc Capital Markets, on the other hand, stated in their research note that they expect to see CDMO reach a price target of $20. The rating they have provided for CDMO stocks is “Overweight” according to the report published on March 14th, 2023.
CDMO Trading at 1.97% from the 50-Day Moving Average
After a stumble in the market that brought CDMO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.72% of loss for the given period.
Volatility was left at 0.48%, however, over the last 30 days, the volatility rate increased by 0.37%, as shares surge +0.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +24.45% upper at present.
During the last 5 trading sessions, CDMO rose by +0.32%, which changed the moving average for the period of 200-days by +85.00% in comparison to the 20-day moving average, which settled at $12.34. In addition, Avid Bioservices Inc saw 0.32% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDMO starting from Richieri Richard A., who sale 2,283 shares at the price of $12.37 back on Jan 10 ’25. After this action, Richieri Richard A. now owns 49,535 shares of Avid Bioservices Inc, valued at $28,241 using the latest closing price.
Richieri Richard A., the Chief Operations Officer of Avid Bioservices Inc, sale 200 shares at $12.37 during a trade that took place back on Jan 10 ’25, which means that Richieri Richard A. is holding 8,785 shares at $2,474 based on the most recent closing price.
Stock Fundamentals for CDMO
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.08 for the gross margin
The net margin for Avid Bioservices Inc stands at -1.01. The total capital return value is set at -0.08. Equity return is now at value -133.29, with -39.04 for asset returns.
Based on Avid Bioservices Inc (CDMO), the company’s capital structure generated 0.82 points at debt to capital in total, while cash flow to debt ratio is standing at -0.02. The debt to equity ratio resting at 4.59. The interest coverage ratio of the stock is -2.42.
Currently, EBITDA for the company is -11.48 million with net debt to EBITDA at -12.18. When we switch over and look at the enterprise to sales, we see a ratio of 6.41. The receivables turnover for the company is 4.98for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.30.
Conclusion
To sum up, Avid Bioservices Inc (CDMO) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
